- Patent Title: Nanoliposome-microbubble conjugate having complex of Cas9 protein, guide RNA inhibiting SRD5A2 gene expression and cationic polymer encapsulated in nanoliposome and composition for ameliorating or treating hair loss containing the same
-
Application No.: US16646899Application Date: 2018-10-17
-
Publication No.: US11766485B2Publication Date: 2023-09-26
- Inventor: Jee-Yeon Ryu , Eun-Jeong Won , Han A Reum Lee , Kyeong-Nam Yu
- Applicant: MOOGENE MEDI CO., LTD.
- Applicant Address: KR Seongnam-si
- Assignee: MOOGENE MEDI CO., LTD.
- Current Assignee: MOOGENE MEDI CO., LTD.
- Current Assignee Address: KR Seongnam-si
- Agency: Sughrue Mion, PLLC
- Priority: KR 20170135017 2017.10.18
- International Application: PCT/KR2018/012251 2018.10.17
- International Announcement: WO2019/078611A 2019.04.25
- Date entered country: 2020-03-12
- Main IPC: A61K47/69
- IPC: A61K47/69 ; C12N9/22 ; C12N15/11

Abstract:
The present invention relates to a nanoliposome-microbubble conjugate, in which a complex of a Cas9 protein, a guide RNA inhibiting SRD5A2 gene expression and a cationic polymer is encapsulated in a nanoliposome, and to a composition for the amelioration or treatment of hair loss containing the same. Currently, drugs used for the treatment of hair loss cause serious side effects such as loss of libido or erectile dysfunction, and hair loss progresses again when drug treatment is stopped. However, when the nanoliposome-microbubble conjugate of the present invention is used, the expression of SRD5A2 inducing hair loss can be fundamentally suppressed, and the treatment of male hair loss can be performed very effectively.
Public/Granted literature
Information query